Loading...

ICCC IMMUCELL CORP Company Mergers 8-K Filing

MMCL

CCC

IMMUCELL CORP

(ICCC)

2026 8-K

Settlement Agreement

Board Changes Announced

Sales Growth Report

Financial Results Release

Management Changes

Sales Results Update

Strategy Change Announcement

Financial Results Announced

Management Changes

Sales Announcement

CEO Appointment

Credit Extension Agreement

Quarterly Results

Financial Statements

Leadership Changes

Financial Statements

Sales Announcement

Management Change

Financial Results

Insurance Settlement

Sales Announcement

Management Change

Contract Amendment

Sales Announcement

Lease Amendment

Financial Results

Financial Results

Lease Amendment

Annual Meeting of Stockholders

Financial Results Announcement

Agreement for Stock Offering

Financial Results

Agreement Termination

Line of Credit Extension

Earnings Reports

Financial Results

Lease Amendment

Financial Results Announcement

Financial Results

Financial Results Announcement

Debt-Equity Swaps

Regulation FD Disclosure

Financial Results

Financial Results Announcement

Financial Results

External Links:

On January 8, 2026, ImmuCell Corporation reported preliminary unaudited sales results for 2025, mentioning a $3.6 million non-cash impairment charge, primarily related to their Re-Tain® assets valued at $15.5 million, which they plan to repurpose for their First Defense® product.

AI Assistant

IMMUCELL CORP

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.